HCA Healthcare, Inc. (NYSE:HCA) Stake Lifted by BOS Asset Management LLC

BOS Asset Management LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 23.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 2,573 shares of the company’s stock after acquiring an additional 495 shares during the period. BOS Asset Management LLC’s holdings in HCA Healthcare were worth $1,046,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of HCA. Fisher Asset Management LLC acquired a new position in shares of HCA Healthcare during the fourth quarter worth approximately $223,000. SageView Advisory Group LLC increased its holdings in shares of HCA Healthcare by 108.7% during the fourth quarter. SageView Advisory Group LLC now owns 2,116 shares of the company’s stock valued at $573,000 after purchasing an additional 1,102 shares during the period. HighPoint Advisor Group LLC acquired a new stake in HCA Healthcare in the fourth quarter worth about $303,000. Nomura Holdings Inc. raised its position in shares of HCA Healthcare by 165.2% during the 4th quarter. Nomura Holdings Inc. now owns 3,978 shares of the company’s stock worth $1,077,000 after buying an additional 2,478 shares in the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of HCA Healthcare by 7.1% in the first quarter. GAMMA Investing LLC now owns 1,086 shares of the company’s stock valued at $362,000 after acquiring an additional 72 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,202 shares of company stock worth $6,407,273. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Price Performance

NYSE HCA opened at $409.23 on Thursday. The firm has a market capitalization of $107.18 billion, a price-to-earnings ratio of 20.40, a price-to-earnings-growth ratio of 1.44 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The company has a 50 day simple moving average of $390.17 and a 200-day simple moving average of $349.03. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $416.72.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the prior year, the business posted $4.29 earnings per share. HCA Healthcare’s revenue for the quarter was up 10.3% compared to the same quarter last year. Equities research analysts predict that HCA Healthcare, Inc. will post 22.51 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on HCA shares. Oppenheimer upped their target price on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. UBS Group lifted their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. KeyCorp assumed coverage on shares of HCA Healthcare in a research report on Friday, October 11th. They set an “overweight” rating and a $475.00 price objective for the company. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. Finally, Truist Financial upped their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $365.65.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.